JAZZ vs MCB · P/E 1988, rev $4.07B vs P/E 13, $798.5M cap
Jazz Pharmaceuticals PLC (JAZZ) versus Metropolitan Bank Holding (MCB) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Metropolitan Bank Holding (MCB) is a banks - regional company listed on US.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
MCB does not have a complete income-statement cache yet.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. MCB currently screens at market cap $798.5M and trailing P/E 12.7.
Not investment advice. Open the JAZZ and MCB stock pages for the full models.
Not investment advice.